Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$24.96 – $61.72
71% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.73B | $4.96B | $5.13B | $7.47B | $5.86B | $6.32B | $6.61B | $8.62B |
| Cost of revenue | $2.81B | $2.96B | $2.86B | $3.30B | $3.43B | $3.67B | $4.11B | $4.32B |
| Gross profit | $1.93B | $2.00B | $2.27B | $4.35B | $2.43B | $2.66B | $2.50B | $4.30B |
| Gross margin | 40.7% | 40.3% | 44.3% | 58.2% | 41.4% | 42.0% | 37.9% | 49.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $1.37B | $1.40B | $1.52B | $3.46B | $2.63B | $1.77B | $2.01B | $3.55B |
| EBITDA | $2.02B | $2.44B | $2.75B | $4.63B | $3.68B | $3.39B | $3.81B | $5.32B |
| Net income | $543.7M | $501.4M | $506.4M | $1.29B | $1.53B | $835.1M | $829.4M | $1.36B |
| Net margin | 11.5% | 10.1% | 9.9% | 17.3% | 26.2% | 13.2% | 12.5% | 15.8% |
| EPS (diluted) | 0.55 | 0.53 | 0.54 | 1.31 | 1.55 | 0.85 | 0.84 | 1.38 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $10.3B | $1.80 | $1.58–$2.10 | 7 |
| 2027 | $10.8B | $1.95 | $1.72–$2.27 | 3 |
| 2028 | $12.2B | $2.28 | $2.01–$2.66 | 4 |
| 2029 | $11.3B | $1.94 | $1.70–$2.26 | 3 |
Forward consensus · source: Financial Modeling Prep
ANTOFAGASTA.PLC ORD
No one on the platform currently holds ANFGF.
No tracked institution reports a position in ANFGF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-17 | $0.4800 | 2026-05-11 |
| 2025-09-05 | $0.1660 | 2025-09-30 |
| 2025-04-22 | $0.2350 | 2025-05-12 |
| 2024-09-06 | $0.0790 | 2024-09-30 |
| 2024-04-18 | $0.2430 | 2024-05-10 |
| 2023-08-31 | $0.1170 | 2023-09-29 |
No one on the platform has traded ANFGF yet.
| $36.8B |
| — |
| GVDNYGivaudan S.A. | $84.47 | -0.11% | $39.0B | — |
| PTCAYPT. Chandra Asri Petrochemical Tbk | $8.71 | +8.88% | $7.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 20.9× earnings vs its 21.8× historical median P/E.
Fair value ≈ $53.27 · price $51.09 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.